Welcome

PharmaSea brings together a broad international, interdisciplinary consortium of 24 partners from 13 countries from industry, academia and non-profit organisations with world-leading researchers in the areas of marine genomics, biosynthesis and chemical structure analysis as well as legal experts. The PharmaSea project focuses on biodiscovery research and the development and commercialisation of new substances from marine organisms. Its primary goal is to collect samples from some of the hottest, deepest and coldest places on the planet. These samples will be screened to uncover marine microbes and new bioactive compounds to evaluate their potential as novel drug leads, antibiotics or ingredients for nutrition or cosmetic applications. PharmaSea is funded by the European Union under its FP7 programme.

News

  • Final General Assembly of the PharmaSea project

    Final General Assembly of the PharmaSea project

    20.02.2017 - The Final General Assembly will take place on the 13-14 March 2017 in Granada, Spain. During the open meeting on the first day, all partners will present their scientific results. During the closed project meeting on the second day, the focus will be on the legacy of the project. More

  • Surveillance Report: „Antimicrobial resistance surveillance in Europe"

    Surveillance Report: „Antimicrobial resistance surveillance in Europe"

    31.01.2017 - Antimicrobial resistance is defined as the “ability of a microorganism to resist the action of one or more antimicrobial agents” (ECDC 2017). The Surveillance Reports highlights that resistance percentages with regard to gram-negative bacteria are increasing. More

  • Video on biodiversity, bioinformatics and biotechnology

    Video on biodiversity, bioinformatics and biotechnology

    14.11.2016 - A documentary film on the hidden biological treasures of the ocean by MicroB3. More

Executive Committee

Institutions

Calendar

All events